Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Profit After Tax Growth (1y) (2010 - 2026)

Charles River Laboratories International (CRL) Profit After Tax Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 7.60%
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 56.76%
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 33.71%
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 57.67%
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -3.37%
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 15.11%
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -11.91%
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 26.93%
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 25.51%
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn -102.81%

Historic Data

Download Data
DateValue
Jun 27, 2026 -102.81%
Dec 27, 2025 -30.28%
Sep 27, 2025 -20.97%
Jun 28, 2025 -44.10%
Mar 29, 2025 -65.26%
Dec 28, 2024 -213.12%
Sep 28, 2024 -20.14%
Jun 29, 2024 -5.21%
Mar 30, 2024 -28.35%
Dec 30, 2023 -0.08%
Sep 30, 2023 -9.83%
Jul 1, 2023 -10.14%
Apr 1, 2023 9.17%
Dec 31, 2022 35.24%
Sep 24, 2022 -7.18%
Jun 25, 2022 23.07%
Mar 26, 2022 48.94%
Dec 25, 2021 -2.35%
Sep 25, 2021 2.19%
Jun 26, 2021 32.88%